Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 2659-2664, June 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santone, K. S.
Right arrow Articles by Powis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santone, K. S.
Right arrow Articles by Powis, G.

Anthracycline-induced Inhibition of a Calcium Action Potential in Differentiated Murine Neuroblastoma Cells

Kenneth S. Santone1, S. George Oakes2, Stuart R. Taylor and Garth Powis3

Department of Oncology [K. S. S., G. P.] and Department of Pharmacology, [S. G. O., S. R. T.] Mayo Clinic and Foundation, Rochester, Minnesota 55904

The effects of some anthracyclines on a Ca2+-dependent action potential have been studied in differentiated murine neuroblastoma cells (N1E-115 clone). The differentiated neuroblastoma cell possesses characteristics of an electrically excitable cell and can generate propagated potential spikes in which Ca2+ is the inward charge carrier. This was shown by the fact that action potentials recorded from differentiated neuroblastoma cells in the presence of 10-7 g of tetrodotoxin per ml, which inhibits active Na+ channels, had a spike amplitude that depended upon the extracellular Ca2+ concentration in a manner close to that predicted by the Nernst equation. The peak potential changed 28.9 mV/decade change in extracellular Ca2+. Local application to a cell of 10-8 M doxorubicin produced inhibition of this Ca2+-dependent action potential within 5 s of drug application and a maximum inhibition of 13% 60 s after drug application. There was almost complete recovery to the initial spike amplitude value within 10 min after removing drug. The same concentration of doxorubicin also produced complete inhibition, without recovery, of a Ca2+-dependent after-discharge which followed the initial action potential in about half the cells studied. Increasing concentrations of doxorubicin produced dose-dependent inhibition of the initial Ca2+-dependent action potential. Cells exposed to 10-5 M doxorubicin showed 88% inhibition of the Ca2+-dependent action potential with no recovery even 10 min after removing the drug. Daunomycin, 10-6 M, produced 90% inhibition of the Ca2+-dependent action potential. Daunomycin aglycone (10-6 M), which lacks antitumor activity, had no significant effect on the Ca2+-dependent action potential. The rapid onset of the drug-induced response together with the low concentrations of anthracyclines needed to inhibit voltage-dependent Ca2+ channels in the neuroblastoma cells suggest a direct effect of anthracyclines on the cell surface membrane. The findings are discussed in light of the possible role of Ca2+ in cancer cells.

1 Recipient of support from NIH Cancer Research Training Grant CA 09441.

2 Recipient of support from NIH Pharmacology Research Training Grant GM 07624.

3 To whom requests for reprints should be addressed, at Department of Oncology, Mayo Clinic and Foundation, 200 First Street, S. W., Rochester, MN 55905.

Received 7/22/85. Revised 11/27/85. Revised 2/18/86. Accepted 2/21/86.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.